International News

Countries Relying on Chinese COVID-19 Vaccine Suffer from Severe COVID Outbreak

Nations like Mongolia, Bahrain and Seychelles, which procured COVID-19 vaccines from Chinese companies Sinopharm and Sinovac Biotech, suffer severe cases of COVID outbreak.

Sentinel Digital Desk

Made in China COVID Vaccine:  Three nation-states put their confidence in widely accessible made-in-China covid-19 vaccines, which would allow them to launch ambitious immunization campaigns at a time when much of the globe was suffering from a lack of vaccines. 

Mongolians were promised a "COVID-free summer." Bahrain announced a "return to normal life." Seychelles, a tiny island nation, wanted to kick-start its economy.

Little did these nations know that relying on China would eventually bite them on their backs. Their hopes of being corona-free turned out to be a farce, and now they are dealing with even higher cases of COVID-19 infections. 

China started its vaccine diplomacy campaign last year, promising a shot that would be both safe and efficacious in preventing extreme symptoms of COVID-19. At the time, it was unclear how successful it and other vaccines would be in preventing transmission. 

Now, evidence from numerous nations suggests that the Chinese vaccines, particularly the latest versions, may be ineffective at preventing the spread of the virus. The experiences of those nations reveal a grim truth of a post-pandemic world. The degree of recovery may be determined by the vaccines administered by governments to their citizens. 

According to Our World in Data, a data tracking initiative, 50 percent to 68 percent of the populations of Seychelles, Chile, Bahrain, and Mongolia have been completely immunized, surpassing the United States. According to data from The New York Times, all four nations were in the top ten with the worst COVID outbreak as recently as last week.

All four are primarily utilizing vaccines manufactured by two Chinese companies, Sinopharm and Sinovac Biotech. 

"We should not observe this trend if the vaccinations are adequately effective," said Jin Dongyan, a virus researcher at the University of Hong Kong. "The Chinese bear responsibility for resolving this." 

Scientists are unsure why certain nations with relatively high immunization rates are seeing new outbreaks. Variants include social restrictions that are too soon relaxed and casual conduct following only the first of a two-shot regimen. However, breakout infections may have long-term effects.

In the United States, around 45 percent of the population has been completely vaccinated, primarily with Pfizer-BioNTech and Moderna vaccines. Over the last six months, the number of reported cases has decreased by 94%. 

Israel gave Pfizer NSE 0.77 percent of the vaccines and has the world's second-highest immunization rate, after only the Seychelles. In Israel, the number of new daily confirmed COVID-19 infections is presently at 4.95 per million people. That figure is higher than 716 instances per million in the Seychelles, which depended heavily on Sinopharm. 

Disparities like these could lead to a world in which three types of countries emerge from the pandemic: wealthy nations that used their resources to secure Pfizer-BioNTech and Moderna shots, poorer countries that are far from immunizing a majority of their citizens, and those that are fully immunized but only partially protected. 

China, along with the more than 90 countries that have received Chinese shots, may wind up in the third category, dealing with periodic lockdowns, testing, and restrictions on daily life for months or years to come. Economies may continue to be stifled. As more individuals dispute the usefulness of Chinese dosages, getting unvaccinated people to line up for injections may become more difficult. 

Beijing viewed vaccine diplomacy as a chance to emerge from the pandemic as a more powerful global force. Xi Jinping, China's top leader, has promised to give a Chinese shot that can be readily stored and carried to millions of people throughout the world. He referred to it as a "global public good." 

Mongolia reaped the benefits, snatching up millions of Sinopharm injections. The small country immediately implemented an immunization program and relaxed limitations. It has now immunized 52% of its people. However, it reported 2,400 new illnesses on Sunday, a quadrupling from the previous month. 

China's Foreign Ministry stated in a statement that it does not believe there is a relationship between the latest outbreaks and its vaccinations. According to the World Health Organization, inoculation rates in certain countries have not reached adequate levels to avoid future outbreaks, and nations must continue to maintain restrictions. 

Although no vaccine completely eliminates transmission and people can become unwell after being immunised, the comparatively low effectiveness rates of Chinese injections have been highlighted as a probable reason of the current outbreaks. 

Despite the increased number of instances, officials in both the Seychelles and Mongolia have supported Sinopharm, claiming that it is beneficial in avoiding severe cases of the disease.